MedTrace Logo

Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women

NCT04556032 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-11-04

No results posted yet for this study

Summary

The objective of this study is to assess the effects of ergothioneine at two doses, compared to placebo, on cognition, mood, and sleep in healthy adult men and women.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

L-Ergothioneine 10 mg/d

L-Ergothioneine 10 mg/d

DIETARY_SUPPLEMENT

L-Ergothioneine 25 mg/d

L-Ergothioneine 25 mg/d

OTHER

Placebo

0 mg/d L-Ergothioneine

Sponsors & Collaborators

  • Blue California Company

    collaborator UNKNOWN

  • Midwest Center for Metabolic and Cardiovascular Research

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-09
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04556032 on ClinicalTrials.gov